Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,162 | 104 | 88,068 | 106,399 | 130,189 |
| TOTAL | $14,470 | $122 | $89,054 | $107,354 | $131,271 |
| Non-Current Assets | |||||
| PPE Net | 21 | 30 | 3,424 | 3,418 | 2,767 |
| Other Non-Current Assets | 0 | 13 | 143 | 143 | 55 |
| TOTAL | $21 | $42 | $3,567 | $3,561 | $2,822 |
| Total Assets | $14,491 | $164 | $92,621 | $110,914 | $134,093 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,075 | N/A | 2,271 |
| Accounts payable and accrued liabilities | 1,198 | 1,308 | 4,369 | 3,471 | 2,584 |
| Accrued Expenses | 1,098 | 602 | 5,422 | 3,214 | 3,734 |
| Other current liabilities | 498 | N/A | N/A | N/A | N/A |
| TOTAL | $2,794 | $1,909 | $12,867 | $6,685 | $8,590 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 17,383 | 14,953 | 3,025 |
| Other Non-Current Liabilities | 0 | 321 | 0 | 0 | 0 |
| TOTAL | $N/A | $321 | $17,383 | $14,953 | $3,025 |
| Total Liabilities | $2,794 | $2,231 | $30,250 | $21,638 | $11,615 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,285 | 1,575 | 1,543 | 1,450 | 1,441 |
| Common Shares | 2 | 1 | 10 | 10 | 10 |
| Retained earnings | -28,938 | -21,939 | -151,948 | -101,075 | -62,254 |
| TOTAL | $11,698 | $-2,066 | $62,371 | $89,277 | $122,478 |
| Total Liabilities And Equity | $14,491 | $164 | $92,621 | $110,915 | $134,093 |